Vimarsana
Biggest News Aggregation in the World

James Frates News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from James Frates. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In James Frates Today - Breaking & Trending Today

Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) Q3 2023 Earnings Call Transcript - Vimarsana News

Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) Q3 2023 Earnings Call Transcript

Published: November 12, 2023

Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) Q3 2023 Earnings Call Transcript November 11, 2023 Operator: Good morning. My name is Keith, and I will be your conference operator today. At this time, I would like to welcome everyone to the Amylyx Pharmaceuticals Third Quarter 2023 Earnings Conference Call. All participants will be in listen-only mode. [Operator Instructions]. […]

Source: yahoo.com
Related Topics:
United StatesJosh CohenJames FratesDiverse CountriesDangerous GangsMargaret OlingerJosh CohenLindsey Allen
Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) Q3 2023 Earnings Call Transcript - Vimarsana News

Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) Q3 2023 Earnings Call Transcript

Published: November 12, 2023

Operator: Good morning. My name is Keith, and I will be your conference operator today.

Source: insidermonkey.com
Related Topics:
United StatesJosh CohenMargaret OlingerLindsey AllenJim FratesCorinne JenkinsJames FratesGeoff MeachamJustin KleeAmylyx Pharmaceuticals Third QuarterEuropean UnionAmylyx Pharmaceuticals IncGoldman SachsAmylyx PharmaceuticalsCall Transcript NovemberInvestor RelationsChief Commercial OfficerChief FinancialPrivate Securities Litigation Reform ActDiverse CountriesDangerous Gangs
Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) Q1 2023 Earnings Call Transcript - Vimarsana News

Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) Q1 2023 Earnings Call Transcript

Published: May 16, 2023

Lindsey Allen: Good afternoon and thank you for joining today to discuss our First Quarter 2023 Earnings.

Source: insidermonkey.com
Related Topics:
United StatesNeena Bitritto GargMarc GoodmanCorinne JenkinsJustin KleeJim FratesLindsey AllenAsia PacificJames FratesMasako NakamuraJosh CohenMargaret OlingerHealth PhotoAmylyx Pharmaceuticals IncGoldman SachsAmylyx PharmaceuticalsCall Transcript MayFirst QuarterChief Commercial OfficerChief FinancialSafe HarborPrivate Securities Litigation Reform ActTbel AbuseridzeLatin AmericaProgressive Supranuclear Palsy
Amylyx's ALS drug again surpasses Wall Street expectations - Vimarsana News

Amylyx's ALS drug again surpasses Wall Street expectations

Published: May 12, 2023

BioPharma

Source: biopharmadive.com
Related Topics:
United KingdomUnited StatesJames FratesJoshua CohenGraig SuvannavejhMargaret OlingerDrug AdministrationAmylyx PharmaceuticalsWall StreetMizuho Securities
Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) Q4 2022 Earnings Call Transcript - Vimarsana News

Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) Q4 2022 Earnings Call Transcript

Published: March 14, 2023

Operator: Good afternoon. My name is Gary, and I will be your conference operator today.

Source: insidermonkey.com
Related Topics:
United StatesKaren FirestoneJosh CohenJim FratesJustin KleeMargaret OlingerJames FratesLindsey AllenGeoff MeachamBiotechnology Sector FundAmylyx Pharmaceuticals IncMost Profitable Renewable Energy StocksAmylyx Pharmaceuticals Fourth QuarterAmylyx Care TeamCanadian Pharmaceutical AllianceAmylyx PharmaceuticalsCall Transcript MarchFull YearInvestor RelationsChief Commercial OfficerChief FinancialSafe HarborPrivate Securities Litigation Reform ActNew England JournalAmylyx Care Team Support